Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Debt - XII | Dead

Total Raised


Last Raised


About Avantis Medical Systems

Avantis Medical Systems is a developer of catheter-based endoscopic devices for detecting colon cancers and polyps. Avantis is developing the Third Eye Retroscope, a new device for detection of colon cancers and polyps that are hidden from the view of a standard colonoscope. The Third Eye Retroscope is passed through the instrument channel of a standard colonoscope until it extends beyond its tip. As it emerges, the device automatically turns around 180 degrees to aim "backward" toward the tip of the colonoscope. Then, as the colonoscope is withdrawn from the colon, the device provides a continuous retrograde view to reveal polyps, cancers and other lesions that might be hidden from the view of a standard colonoscope. Colonoscopy is widely regarded as the "gold standard" for detection of abnormalities in the colon. However, research has revealed that many polyps and cancers can be missed during colonoscopy, especially if they lie behind folds in the colon wall. This new device reveals the opposite side of those folds.

Avantis Medical Systems Headquarters Location

2367 Bering Drive

San Jose, California, 95131,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Avantis Medical Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Avantis Medical Systems is included in 3 Expert Collections, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Medical Devices

11,575 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Avantis Medical Systems Patents

Avantis Medical Systems has filed 21 patents.

The 3 most popular patent topics include:

  • Endoscopy
  • 3D imaging
  • Autoimmune diseases
patents chart

Application Date

Grant Date


Related Topics




Endoscopy, Digestive system surgery, Image processing, 3D imaging, Medical equipment


Application Date


Grant Date



Related Topics

Endoscopy, Digestive system surgery, Image processing, 3D imaging, Medical equipment



Latest Avantis Medical Systems News

Avantis Medical Systems Inc Medical Equipment Deals and Alliances Profile Report Updated 11052018 Prices from USD $250

Jul 31, 2018

Avantis Medical Systems Inc Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250 21:06 EDT 30 Jul 2018 | BioPortfolio Reports Summary Avantis Medical Systems Inc AMS is a medical device company that provides visualization technology solutions. The company uses its technology platform and software analysis for the screening and early detection of cancer . It offers products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two sideviewing cameras supplement and the colonoscopy's forward view, providing standard adult and pediatric colonoscopies; and maintain a free working channel to allow passage of instruments. The company's single camera colonoscopy devices offer single video camera it provides side angle views to provide brighter images. It markets its products through a network of distributors in the US. AMS is headquartered in San Jose, California, the US. Avantis Medical Systems Inc Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • When was Avantis Medical Systems founded?

    Avantis Medical Systems was founded in 2004.

  • Where is Avantis Medical Systems's headquarters?

    Avantis Medical Systems's headquarters is located at 2367 Bering Drive, San Jose.

  • What is Avantis Medical Systems's latest funding round?

    Avantis Medical Systems's latest funding round is Debt - XII.

  • How much did Avantis Medical Systems raise?

    Avantis Medical Systems raised a total of $71.01M.

  • Who are the investors of Avantis Medical Systems?

    Investors of Avantis Medical Systems include Montreux Equity Partners, Century Bank, MedFocus Fund, BioStar Capital, Qualifying Therapeutic Discovery Project and 3 more.

  • Who are Avantis Medical Systems's competitors?

    Competitors of Avantis Medical Systems include OrthAlign, NeuroSky, Endotronix, Paragon Medical, Xlumena and 13 more.

You May Also Like


ActiVein develops a patented, dual-action intravenous (IV) catheter that aims to replace the standard conventional "hospital IV line" by enabling both fluid infusion and blood withdrawal using a single vein over an entire hospitalization period, whereas the currently used device aims to allow, regularly, fluid infusion only.


C2C is a medical device company developing a portfolio of medical devices.


VytronUS is developing an integrated imaging and ablation platform for cardiac electrophysiologists. Harnessing the capability of ultrasound energy, the company's system creates a high resolution image of the interior of the heart for procedure planning and allows the physician to draw a desired treatment pattern on the image at the workstation.

Medtronic Sterile Systems

Medtronic Biomedicus, Inc, Sterile Systems Operation has been providing EtO Sterilization services since 1990. Sterile Systems has four large chambers and a single smaller one. Because the company have chambers of multiple sizes, the company can easily handle loads from one cart to eight pallets. Sterile Systems is owned by Medtronic, a publicly traded medical device manufacturers. The company are able to leverage the benefits of being part of a multi-national corporation, but still offer the kind of customer service and personalized attention users get from design to sterilized product.

Precision Parts International

PPI was formed from the merger of three companies (MPI International, Skill Tool & Die, and Precision Gear) to manufacture complex, high-precision metal components for the automotive, defense, medical device and construction industries.


Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.